Jacobi Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$391K Sell
4,719
-147
-3% -$12.2K 0.03% 444
2025
Q1
$395K Sell
4,866
-114
-2% -$9.25K 0.03% 420
2024
Q4
$449K Sell
4,980
-93
-2% -$8.38K 0.03% 373
2024
Q3
$501K Sell
5,073
-257
-5% -$25.4K 0.04% 347
2024
Q2
$494K Sell
5,330
-57
-1% -$5.28K 0.04% 317
2024
Q1
$511K Hold
5,387
0.05% 305
2023
Q4
$481K Sell
5,387
-22
-0.4% -$1.96K 0.05% 298
2023
Q3
$395K Buy
5,409
+32
+0.6% +$2.34K 0.04% 308
2023
Q2
$447K Sell
5,377
-238
-4% -$19.8K 0.05% 292
2023
Q1
$428K Buy
5,615
+365
+7% +$27.8K 0.05% 292
2022
Q4
$436K Sell
5,250
-15
-0.3% -$1.25K 0.05% 286
2022
Q3
$418K Sell
5,265
-95
-2% -$7.54K 0.06% 278
2022
Q2
$398K Buy
5,360
+745
+16% +$55.3K 0.05% 290
2022
Q1
$415K Buy
4,615
+595
+15% +$53.5K 0.05% 294
2021
Q4
$450K Sell
4,020
-72
-2% -$8.06K 0.05% 291
2021
Q3
$514K Hold
4,092
0.07% 242
2021
Q2
$554K Hold
4,092
0.07% 220
2021
Q1
$555K Buy
4,092
+4
+0.1% +$543 0.08% 204
2020
Q4
$575K Sell
4,088
-35
-0.8% -$4.92K 0.09% 179
2020
Q3
$459K Buy
4,123
+3
+0.1% +$334 0.08% 195
2020
Q2
$461K Hold
4,120
0.09% 186
2020
Q1
$319K Buy
4,120
+592
+17% +$45.8K 0.07% 207
2019
Q4
$336K Hold
3,528
0.06% 232
2019
Q3
$269K Sell
3,528
-29
-0.8% -$2.21K 0.05% 246
2019
Q2
$312K Hold
3,557
0.06% 233
2019
Q1
$322K Sell
3,557
-49
-1% -$4.44K 0.08% 173
2018
Q4
$259K Sell
3,606
-614
-15% -$44.1K 0.07% 186
2018
Q3
$405K Sell
4,220
-37
-0.9% -$3.55K 0.11% 118
2018
Q2
$405K Buy
4,257
+88
+2% +$8.37K 0.12% 116
2018
Q1
$350K Buy
4,169
+96
+2% +$8.06K 0.1% 115
2017
Q4
$348K Sell
4,073
-821
-17% -$70.1K 0.11% 105
2017
Q3
$429K Buy
4,894
+118
+2% +$10.3K 0.15% 85
2017
Q2
$368K Buy
4,776
+2,376
+99% +$183K 0.14% 76
2017
Q1
$161K Buy
+2,400
New +$161K 0.08% 115